NEU neuren pharmaceuticals limited

Ann: Q2 2024 update, page-27

  1. 8,635 Posts.
    lightbulb Created with Sketch. 2611
    You said 11/12 PE and forward will be higher. Yet you neglected to articulate the forward P/E which is over double that. Funny that.

    You asked for a justification of why it's overvalued, I think i gave you a pretty clear one.

    Without sales growth, NEU is going to get dumped. It shouldn't be struggling to grow sales this early in it's journey, it should be a hyper growth phase and it isn't.

    Nothing you or I say will change that fact, butfor angelman results Friday will be a very deep red day.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.100(0.80%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.44 $12.73 $12.13 $11.07M 885.6K

Buyers (Bids)

No. Vol. Price($)
1 1215 $12.52
 

Sellers (Offers)

Price($) Vol. No.
$12.54 804 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.